vTv Therapeutics Inc. Deferred Tax Assets, Operating Loss Carryforwards
vTv Therapeutics Inc. (VTVT) had Deferred Tax Assets, Operating Loss Carryforwards of $37.09 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $37.09M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $27.82M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $23.72M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $20.31M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $37.09M 10-K · filed 2026-03-10 | |
| 2024-12-31 | $27.82M 10-K · filed 2026-03-10 | |
| 2023-12-31 | $23.72M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $20.31M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $20.91M 10-K · filed 2023-03-06 | |
| 2020-12-31 | $17.34M 10-K · filed 2022-03-29 | |
| 2019-12-31 | $14.54M 10-K · filed 2021-02-24 | |
| 2018-12-31 | $11.40M 10-K · filed 2020-02-21 | $12.75M 10-K · filed 2019-02-26 |
| 2017-12-31 | $9.02M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $8.19M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $2.54M 10-K · filed 2017-02-24 |